Back to company

OLANDER CLINICAL CONSULTING K/S: Financial statements 2025

CVR: 35860177

OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. That is an increase of 4.8% compared with the year before. Equity amounted to DKK 303,261. The solvency ratio was 43.4%. The company had 1 employee in the financial year.

Gross Profit
2,099,449 kr.
Profit/Loss
2,057,637 kr.
Equity
303,261 kr.
Total Assets
698,523 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-2.1 mio.2.1 mio.303 t.1
2024-2 mio.2 mio.555 t.1
2023-1.9 mio.1.9 mio.622 t.0
2022-1.9 mio.1.9 mio.621 t.-
2021-1.8 mio.1.8 mio.687 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like OLANDER CLINICAL CONSULTING K/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

OLANDER CLINICAL CONSULTING K/S: The 2024 annual report is outJun 11, 2025

OLANDER CLINICAL CONSULTING K/S has published its annual report for 2024. Gross profit came to DKK 2,004,138, and the net result was DKK 2,004,688.

About OLANDER CLINICAL CONSULTING K/S

OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity amounted to DKK 303,261.